Close ties: An exploratory Colored Eco-Genetic Relationship Map (CEGRM) study of social connections of men in Familial Testicular Cancer (FTC) families

Hereditary Cancer in Clinical Practice

Volumn 10, Issue 1, 2012, Pages

  Peters, June A ^a   Kenen, Regina ^b   Hoskins, Lindsey M ^a   Glenn, Gladys M ^a   Kratz, Christian ^a   Greene, Mark H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b The College of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; EMOTION; EXPLORATORY RESEARCH; FAMILIAL CANCER; FAMILIAL TESTICULAR CANCER; FAMILY HISTORY; FEASIBILITY STUDY; GENE MAPPING; HUMAN; MALE; MEDICAL HISTORY; PERIPHERAL NEUROPATHY; SOCIAL CONNECTION; SOCIAL NETWORK; SOCIAL SUPPORT; TESTIS CANCER;

EID: 84862115233     PISSN: 17312302     EISSN: 18974287     Source Type: Journal    
DOI: 10.1186/1897-4287-10-2     Document Type: Article

References (76)

1. Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA. International patterns and trends in testis cancer incidence. Int J Cancer 2005, 115:822-827. 10.1002/ijc.20931, 15704170.
2. Rasmussen F, Gunnell D, Ekbom A, Hallqvist J, Tynelius P. Birth weight, adult height, and testicular cancer: cohort study of 337,249 Swedish young men. Cancer Causes Control 2003, 14:595-598. 10.1023/A:1024860826830, 12948291.
3. Korde LA, Premkumar A, Mueller C, Rosenberg P, Soho C, Bratslavsky G, Greene MH. Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives. Br J Cancer 2008, 99:1748-1753. 10.1038/sj.bjc.6604704, 2584936,2584936, 18841155.
4. Heimdal K, Olsson H, Tretli S, Flodgren P, Borresen AL, Fossa SD. Familial testicular cancer in Norway and southern Sweden. Br J Cancer 1996, 73:964-969. 10.1038/bjc.1996.173, 2074255, 8611416.
5. Heimdal K, Olsson H, Tretli S, Flodgren P, Borresen AL, Fossa SD. Risk of cancer in relatives of testicular cancer patients. Br J Cancer 1996, 73:970-973. 10.1038/bjc.1996.174, 2074274, 8611417.
6. Gritz ER, Wellisch DK, Wang HJ, Siau J, Landsverk JA, Cosgrove MD. Long-term effects of testicular cancer on sexual functioning in married-couples. Cancer 1989, 64:1560-1567. 10.1002/1097-0142(19891001)64:7<1560::AID-CNCR2820640735>3.0.CO;2-B, 2789097.
7. Tuinman MA, Hoekstra HJ, Sleijfer DT, Fleer J, Gritz ER. Sexual function in testicular cancer patients during the first year after diagnosis: a multi center study. Psychooncology 2006, 15:S437-S437.
8. Arai Y, Kawakita M, Hida S, Terachi T, Okada Y, Yoshida O. Psychosocial aspects in long-term survivors of testicular cancer. J Urol 1996, 155:574-578. 10.1016/S0022-5347(01)66452-8, 8558663.
9. Joly F, Héron JF, Kalusinski L, Bottet P, Brune D, Allouache N, Macé-Lesec'h J, Couëtte JE, Pény J, Henry-Amar M. Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol 2002, 20:73-80. 10.1200/JCO.20.1.73, 11773156.
10. Smith KR, West JA, Croyle RT, Botkin JR. Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing. Cancer Epidemiol Biomarkers Prev 1999, 8:385-392.
11. Stromsvik N, Raheim M, Yen N, Gjengedal E. Men in the women's world of hereditary breast and ovarian cancer-a systematic review. Fam Cancer 2009, 8:221-229. 10.1007/s10689-009-9232-1, 19165626.
12. d'Agincourt-Canning L. A gift or a yoke? Women's and men's responses to genetic risk information from BRCA1 and BRCA2 testing. Clin Genet 2006, 70:462-472. 10.1111/j.1399-0004.2006.00720.x, 17100990.
13. Hallowell N, Ardern-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C, Watson M. Men's decision-making about predictive BRCA1/2 testing: the role of family. J Genet Couns 2005, 14:207-217. 10.1007/s10897-005-0384-3, 15959652.
14. Lodder L, Frets PG, Trijsburg RW, Tibben A, Meijers-Heijboer EJ, Duivenvoorden HJ, Wagner A, van der Meer CA, Devilee P, Cornelisse CJ, Niermeijer MF. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. Eur J Hum Genet 2001, 9:492-500. 10.1038/sj.ejhg.5200668, 11464240.
15. Graves K, Gatammah R, Peshkin B, Krieger A, Gell C, Valdimarsdottir H, Schwartz M. BRCA1/2 genetic testing uptake and psychosocial outcomes in men. Fam Cancer 2011, 10:213-223. 10.1007/s10689-011-9425-2, 21365268.
16. Daly M. The impact of social roles on the experience of men in BRCA1/2 families: implications for counseling. J Genet Couns 2009, 18:42-48. 10.1007/s10897-008-9183-y, 2629810, 18688698.
17. Kenen R, Arden-Jones A, Eeles R. Healthy women from suspected hereditary breast and ovarian cancer families: the significant others in their lives. Eur J Cancer Care 2004, 13:169-179.
18. Kenen R, Ardern-Jones A, Eeles R. We are talking, but are they listening? Communication patterns in families with a history of breast/Ovarian cancer (HBOC). Psychooncology 2004, 13:335-345. 10.1002/pon.745, 15133774.
19. Koehly LM, Peters JA, Kenen R, Hoskins LM, Ersig AL, Kuhn NR, Loud JT, Greene MH. Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: implications for family health communication interventions. Am J Public Health 2009, 99:2203-2209. 10.2105/AJPH.2008.154096, 2775786,2775786, 19833996.
20. Peters JA, Kenen R, Hoskins LM, Koehly LM, Graubard B, Loud JT, Greene MH. Unpacking the Blockers: Understanding Perceptions and Social Constraints of Health Communication in Hereditary Breast Ovarian Cancer (HBOC) Susceptibility Families. J Genet Counseling 2011, 20:450-464.
21. Koehly LM, Peters JA, Kenen R, Hoskins LM, Ersig AL, Kuhn NR, Loud JT, Greene MH. Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: Implications for family health communication interventions. Am J Public Health 2009, 99:2203-2209. 10.2105/AJPH.2008.154096, 2775786,2775786, 19833996.
22. Kenen R, Peters J. The colored, eco-genetic relationship map (CEGRM): a conceptual approach and tool for genetic counseling research. J Genet Couns 2001, 10:289-309.
23. Koehly LM, Peters JA, Kuhn N, Hoskins L, Letocha A, Kenen R, Loud J, Greene MH. Sisters in hereditary breast and ovarian cancer families: communal coping, social integration, and psychological well-being. Psychooncology 2008, 17:812-821. 10.1002/pon.1373, 3125979, 18688790.
24. Peters J, Kenen R, Giusti R, Loud J, Weissman N, Greene M. Exploratory study of the feasibility and utility of the colored eco-genetic relationship map (CEGRM) in women at high genetic risk of developing breast cancer. Am J Med Genet A 2004, 130A:258-264. 10.1002/ajmg.a.30271, 15378540.
25. Peters JA, Hoskins L, Prindiville S, Kenen R, Greene MH. Evolution of the colored ecogenetic relationship map (CEGRM) for assessing social functioning in women in hereditary breast-ovarian (HBOC) families. J Genet Couns 2006, 15:477-489. 10.1007/s10897-006-9042-7, 17111216.
26. Driessnack M. Using the colored eco-genetic relationship map with children. Nurs Res 2009, 58:304-311. 10.1097/NNR.0b013e3181b49928, 19752670.
27. Derogatis L. Brief Symptom Inventory 18 (BSI 18) administration, scoring, and procedures manual 2001, Minneapolis: National Computer Systems.
28. Strauss A, Corbin J. Basics of qualitative research: Techniques and procedures for Developing Grounded Theory 1998, Thousand Oaks: Sage Publications.
29. Bailey CA. A Guide to Qualitative Field Research 2007, Thousand Oaks, CA: Pine Forge Press, 2.
30. Mai PL, Friedlander M, Tucker K, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Bonaiti-Pellie C, et al. The International Testicular Cancer Linkage Consortium: A clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred. Urol Oncol 2010, 28(5):492-499. Epub 2009 Jan 22, 10.1016/j.urolonc.2008.10.004, 2891341, 19162511.
31. Giambartolomei C, Mueller CM, Greene MH, Korde LA. A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome. Cancer Epidemiol 2009, 33:31-36. 10.1016/j.canep.2009.04.015, 2735217, 19679044.
32. Goffman E. Stigma: Notes on the Management of Spoiled Identity 1956, New York: Simon & Schuster.
33. Peters JA, Kenen R, Giusti R, Loud J, Weissman N, Greene MH. Exploratory study of the feasibility and utility of the Colored Eco-Genetic Relationship Map (CEGRM) in women at high genetic risk of developing breast cancer. Am J Med Genet 2004, 130A:258-264. 10.1002/ajmg.a.30271, 15378540.
34. Fleer J, Hoekstra HJ, Sleijfer DT, Hoekstra-Weebers JEHM. Quality of life of survivors of testicular germ cell cancer: a review of the literature. Support Care Cancer 2004, 12:476-486.
35. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011, 12:160-174. 10.1016/S1470-2045(11)70002-X, 21251875.
36. Schover LR. Sexuality and fertility in urologic cancer patients. Cancer 1987, 60:553-558. 10.1002/1097-0142(19870801)60:3+<553::AID-CNCR2820601519>3.0.CO;2-3, 3036334.
37. Schover LR, Von Eschenbach AC. Sexual and marital relationships after treatment for nonseminomatous testicular cancer. Urology 1985, 25:251-255. 10.1016/0090-4295(85)90322-X, 4038829.
38. Luckett T, Butow PN, King MT, Olver IN. Psycho-social issues in long-term survivors of testicular cancer: directions for future research. Asia Pac J Clin Oncol 2008, 4:125-131.
39. Bowman JM. Gender role orientation and relational closeness. Journal of Men's Studies 2008, 16:316-330. 10.3149/jms.1603.316, 22416251.
40. Kenen RH, Shapiro PJ, Friedman S, Coyne JC. Peer-support in coping with medical uncertainty: discussion of oophorectomy and hormone replacement therapy on a web-based message board. Psychooncology 2007, 16:763-771. 10.1002/pon.1152, 17230435.
41. Courtenay W. Making health manly: social marketing and men's health. Journal of Men's Health and Gender 2004, 1:275-276. 10.1016/j.jmhg.2004.07.027, 22416251.
42. Nicholas DR. Men, masculinity, and cancer: risk-factor behaviors, early detection, and psychosocial adaptation. J Am Coll Health 2000, 49:27-33. 10.1080/07448480009596279, 10967881.
43. Moynihan C. Men, women, gender and cancer. Eur J Cancer Care 2002, 11:166-172.
44. Moynihan C. Theories of masculinity. BMJ 1998, 317:1072-1075. 10.1136/bmj.317.7165.1072, 1114070, 9774301.
45. Zorn TE, Gregory KW. Learning the ropes together: assimilation and friendship development among first-year male medical students. Health Commun 2005, 17:211-231. 10.1207/s15327027hc1703_1, 15855070.
46. Mahalik JR, Burns SM. Predicting health behaviors in young men that put them at risk for heart disease. Psychology of Men and Masculinity 2011, 12:1-12.
47. Levant RF, Wimer DJ, Williams CM. An evaluation of the Health Behavior Inventory20 (HBI-20) and its relationships to masculinity and attitudes towards seeking psychological help among college men. Psychology of Men and Masculinity 2011, 12:26-41.
48. Courtenay WH. Constructions of masculinity and their influence on men's wellbeing: a theory of gender and health. Soc Sci Med 2000, 50:1385-1401. 10.1016/S0277-9536(99)00390-1, 10741575.
49. Moynihan C, Norman AR, Barbachano Y, Burchell L, Huddart R, Dearnaley DP, Horwich A. Prospective study of factors predicting adherence to medical advice in men with testicular cancer. J Clin Oncol 2009, 27:2144-2150. 10.1200/JCO.2008.16.1901, 2738633, 19307514.
50. Vadaparampil ST, Moser RP, Loud J, Peters JA, Greene MH, Korde L. Factors associated with testicular self-examination among unaffected men from multiple-case testicular cancer families. Hered Cancer Clin Prac 2009, 7(1):11.
51. Peters JA, Beckjord EB, Banda Ryan DR, Carr AG, Vadaparampil ST, Loud JT, Korde L, Greene MH. Testicular cancer and genetics knowledge among familial testicular cancer family members. J Genet Couns 2008, 17:351-364. 10.1007/s10897-008-9153-4, 3111072, 18481162.
52. Doka KJ. Grief: the constant companion of illness. Anesthesiol Clin North America 2006, 24:205-212.
53. Martin TL, Wang WC. A pilot study of the development of a tool to measure instrumental and intuitive styles of grieving. Omega: Journal of Death and Dying 2006, 53:263-276.
54. Gritz ER, Wellisch DK, Siau J, Wang HJ. Long-term effects of testicular cancer on marital relationships. Psychosomatics 1990, 31:301-312. 10.1016/S0033-3182(90)72168-8, 2167494.
55. Heimdal K, Olsson H, Tretli S, Flodgren P, Borresen AL, Fossa SD. Risk of cancer in relatives of testicular cancer patients. Br J Cancer 1996, 73(7):970-973. 10.1038/bjc.1996.174, 2074274, 8611417.
56. Andersson E, Nilsson R, Toren K. Testicular cancer among Swedish pulp and paper workers. Am J Ind Med 2003, 43(6):642-646. 10.1002/ajim.10223, 12768614.
57. Bates MN, Fawcett J, Garrett N, Arnold R, Pearce N, Woodward A. Is testicular cancer an occupational disease of fire fighters?. Am J Ind Med 2001, 40(3):263-270. 10.1002/ajim.1097, 11598972.
58. Aschim EL, Grotmol T, Tretli S, Haugen TB. Is there an association between maternal weight and the risk of testicular cancer? An epidemiologic study of Norwegian data with emphasis on World War II. Int J Cancer 2005, 116(2):327-330. 10.1002/ijc.21044, 15800917.
59. Moline JM, Golden AL, Bar-Chama N, Smith E, Rauch ME, Chapin RE, Perreault SD, Schrader SM, Suk WA, Landrigan PJ. Exposure to hazardous substances and male reproductive health: A research framework. Environ Heal Perspect 2000, 108(9):803-813.
60. Mirabello L, Savage SA, Korde L, Gadalla SM, Greene MH. LINE-1 methylation is inherited in familial testicular cancer kindreds. BMC Med Genet 2010, 11:77. 2880977, 20478068.
61. Korde LA, Premkumar A, Mueller C, Rosenberg P, Soho C, Bratslavsky G, Greene MH. Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives. Br J Cancer 2008, 99(10):1748-1753. 10.1038/sj.bjc.6604704, 2584936,2584936, 18841155.
62. Bates MN, Lane L. Testicular Cancer in Fire Fighters-A Cluster Investigation. New Zealand Medical Journal 1995, 108(1006):334-337.
63. de Gouveia Brazao CA, Pierik FH, Oosterhuis JW, Dohle GR, Looijenga LH, Weber RF. Bilateral testicular microlithiasis predicts the presence of the precursor of testicular germ cell tumors in subfertile men. J Urol 2004, 171(1):158-160. 10.1097/01.ju.0000093440.47816.88, 14665866.
64. Coffey J, Huddart RA, Elliott F, Sohaib SA, Parker E, Dudakia D, Pugh JL, Easton DF, Bishop DT, Stratton MR, et al. Testicular microlithiasis as a familial risk factor for testicular germ cell tumour. Br J Cancer 2007, 97(12):1701-1706. 10.1038/sj.bjc.6604060, 2360292, 17971766.
65. Ringdahl E, Claybrook K, Teague JL, Northrup M. Testicular microlithiasis and its relation to testicular cancer on ultrasound findings of symptomatic men. J Urol 2004, 172(5):1904-1906. 10.1097/01.ju.0000142449.47356.29, 15540751.
66. Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, et al. Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet 2006, 15(3):443-451.
67. Rapley EA, Hockley S, Warren W, Johnson L, Huddart R, Crockford G, Forman D, Leahy MG, Oliver DT, Tucker K, et al. Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer 2004, 90(12):2397-2401. 2410291, 15150569.
68. Rapley EA, Turnbull C, Al Olama AA, Dermitzakis ET, Linger R, Huddart RA, Renwick A, Hughes D, Hines S, Seal S, et al. A genome-wide association study of testicular germ cell tumor. Nat Genet 2009, 41(7):807-810. 10.1038/ng.394, 2871592, 19483681.
69. Greene MH, Kratz CP, Mai PL, Mueller C, Peters JA, Bratslavsky G, Ling A, Choyke PM, Premkumar A, Bracci J, et al. Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocrine-Related Cancer 2010, 17(2):R109-R121. 10.1677/ERC-09-0254, 3101798, 20228134.
70. Turnbull C, Rapley EA, Seal S, Pernet D, Renwick A, Hughes D, Ricketts M, Linger R, Nsengimana J, Deloukas P, et al. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet 2010, 42(7):604-607. 10.1038/ng.607, 20543847.
71. Kanetsky PA, Mitra N, Vardhanabhuti S, Li MY, Vaughn DJ, Letrero R, Ciosek SL, Doody DR, Smith LM, Weaver J, et al. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet 2009, 41(7):811-U865. 10.1038/ng.393, 2865677, 19483682.
72. Kratz CP, Han SS, Rosenberg PS, Berndt SI, Burdett L, Yeager M, Korde LA, Mai PL, Pfeiffer R, Greene MH. Variants in or near KITLG, BAK1, DMRT1, and TERTCLPTM1L predispose to familial testicular germ cell tumour. J Med Genet 2011, 48(7):473-476. 10.1136/jmedgenet-2011-100001, 21617256.
73. Kratz CP, Mai PL, Greene MH. Familial testicular germ cell tumours. Best Practice and Research: Clinical Endocrinology and Metabolism 2010, 24(3):503-513.
74. Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, et al. The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet 2005, 77(6):1034-1043. 10.1086/498455, 1285161, 16380914.
75. di Pietro A, de Vries EGE, Gietema JA, Spierings DCJ, de Jong S. Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours. Int J Biochem Cell Biol 2005, 37(12):2437-2456. 10.1016/j.biocel.2005.06.014, 16099193.
76. Bleyer A. Latest Estimates of Survival Rates of the 24 Most Common Cancers in Adolescent and Young Adult Americans. J Adolesc Young Adult Oncol 2011, 1(1):37-42.